Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial.
Vicent-Gil M, Raventós B, Marín-Martínez ED, González-Simarro S, Martínez-Arán A, Bonnin CDM, Trujols J, Pérez-Blanco J, de Diego-Adeliño J, Puigdemont D, Serra-Blasco M, Cardoner N, Portella MJ. Vicent-Gil M, et al. BMC Psychiatry. 2019 May 6;19(1):135. doi: 10.1186/s12888-019-2117-4. BMC Psychiatry. 2019. PMID: 31060604 Free PMC article. Clinical Trial.
Randomized clinical trial of integral cognitive remediation program for major depression (INCREM).
Vicent-Gil M, González-Simarro S, Raventós B, Vera J, Marín Martínez ED, Sabaté-Cao C, Pérez-Blanco J, Puigdemont D, de Diego-Adeliño J, Alemany C, Serra-Blasco M, Cardoner N, Portella MJ. Vicent-Gil M, et al. Among authors: perez blanco j. J Affect Disord. 2022 Aug 1;310:189-197. doi: 10.1016/j.jad.2022.05.016. Epub 2022 May 8. J Affect Disord. 2022. PMID: 35545155 Clinical Trial.
Brain metabolic changes in patients with treatment resistant schizophrenia treated with deep brain stimulation: A series of cases.
Roldán A, Portella MJ, Sampedro F, Alonso-Solís A, Sarró S, Rabella M, Grasa EM, Álvarez E, Rodríguez R, Camacho V, Fernandez-León A, Fuentes F, Pérez-Blanco J, Pérez V, Mckenna P, Pomarol-Clotet E, Corripio I. Roldán A, et al. Among authors: perez blanco j. J Psychiatr Res. 2020 Aug;127:57-61. doi: 10.1016/j.jpsychires.2020.05.016. Epub 2020 May 19. J Psychiatr Res. 2020. PMID: 32485433
Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J, Vieta E. Garriga M, et al. Eur Neuropsychopharmacol. 2017 Oct;27(10):959-969. doi: 10.1016/j.euroneuro.2017.08.429. Epub 2017 Sep 4. Eur Neuropsychopharmacol. 2017. PMID: 28882405 Clinical Trial.
A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M. Vieta E, et al. Int J Neuropsychopharmacol. 2008 Jun;11(4):445-52. doi: 10.1017/S1461145708008596. Epub 2008 Mar 17. Int J Neuropsychopharmacol. 2008. PMID: 18346292 Free article. Clinical Trial.
32 results